Keyphrases
Anti-cyclic Citrullinated Peptide Antibody (anti-CCP)
14%
Biologic DMARDs
14%
C-reactive Protein Level
14%
Clinical Variables
14%
Combined Treatment
14%
Consecutive Patients
14%
Conventional Disease-modifying Antirheumatic Drug
42%
Cross-sectional Observational Study
14%
Disease Activity
28%
Disease Activity Score 28 (DAS28)
100%
Disease Control
14%
Disease Duration
28%
Disease Remission
28%
Disease-modifying Antirheumatic Drugs (DMARDs)
14%
Drug Treatment
14%
Inception Cohort
100%
Low Disease Activity
14%
Medical Files
14%
Monotherapy
14%
Outpatient Clinic
14%
Remission
28%
Rheumatoid Arthritis
100%
Rheumatoid Factor
14%
Rheumatologists
14%
Rheumatology
14%
Routine Clinical Practice
14%
Single Center
100%
Therapeutic Target
14%
Tight Control
14%
Treat-to-target
14%
Treatment Variable
14%
Medicine and Dentistry
C Reactive Protein
20%
Cross Sectional Study
100%
Disease
20%
Disease Activity
60%
Disease Duration
20%
Disease Modifying Antirheumatic Drug
60%
Disease-Modifying Antirheumatic Drug
40%
Drug Therapy
20%
Monotherapy
20%
Outpatient
20%
Rheumatoid Arthritis
100%
Rheumatoid Factor
20%
Rheumatology
20%
Spontaneous Remission
40%
Pharmacology, Toxicology and Pharmaceutical Science
C Reactive Protein
20%
Cross-Sectional Study
100%
Disease
20%
Disease Activity
60%
Disease Duration
20%
Disease Modifying Antirheumatic Drug
60%
Monotherapy
20%
Pharmacotherapy
20%
Remission
80%
Rheumatoid Arthritis
100%
Rheumatoid Factor
20%
Neuroscience
C-Reactive Protein
20%
Disease-Modifying Antirheumatic Drug
60%
Rheumatoid Arthritis
100%
Rheumatoid Factor
20%
Rheumatology
20%
Biochemistry, Genetics and Molecular Biology
C-Reactive Protein
50%
Cross Sectional Study
100%
Rheumatoid Factor
50%
Immunology and Microbiology
C-Reactive Protein
20%
Disease-Modifying Antirheumatic Drug
60%
Inflammatory Arthritis
100%
Rheumatoid Factor
20%